|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.25 SEK | -0.97% |
|
+0.49% | +15.69% |
Vimab Group AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 114.06 million compared to SEK 66.43 million a year ago. Revenue was SEK 114.82 million compared to SEK 66.66 million a year ago.
Net loss was SEK 5.96 million compared to SEK 15.65 million a year ago. Basic loss per share from continuing operations was SEK 0.3.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.69% | 20.88M | |
| +6.13% | 7.41B | |
| -32.64% | 3.24B | |
| +5.82% | 2.66B | |
| +11.38% | 1.75B | |
| -9.32% | 1.08B | |
| +31.69% | 907M | |
| -7.64% | 714M | |
| -3.60% | 606M | |
| -8.30% | 539M |
VIMAB GROUP AB 
